Key result
Pulmonary lymphangitic carcinomatosis in pancreatic cancer progresses to fatal hypoxic respiratory failure within six weeks.
Why the study?
Pulmonary lymphangitic carcinomatosis carries a poor prognosis and proper knowledge of its clinical presentation is important for timely diagnosis and treatment.
Case Report (n=1)
Pulmonary lymphangitic carcinomatosis is a rare manifestation of malignancy that carries a poor prognosis and can present with rapid deterioration requiring mechanical ventilation.
Answers are grounded in this paper and cite their sources.
Signals poor prognosis with possible ventilatory failure in lymphangitic carcinomatosis; leaves open optimal management strategies.
Pulmonary lymphangitic carcinomatosis (PLC) is defined as a tumor in the lung lymphatic vessels. It is rarely seen as a result of malignancy and generally carries a poor prognosis. Proper knowledge of the clinical presentation is important for physicians to be aware of in order to consider a diagnosis of PLC. We present the case of a 52-year-old Caucasian gentleman who initially came to the hospital with a three-week history of dyspnea. In the hospital, a diagnosis of Stage 4 pancreatic cancer with a lymphangitic spread of the tumor to the lungs was made. Despite optimal treatment, the patient required mechanical ventilation for acute hypoxic respiratory failure. PLC is a relatively rare manifestation of malignancy; yet, it generally carries a poor prognosis. It may occur during the course of malignancy or may represent as the first findings in malignancy. It is important for physicians to be aware of the clinical presentations of PLC in order to ensure timely treatment. Oftentimes, PLC can be diagnosed through clinical judgment alone without the need for radiological support and other invasive measures.
No takes yet. Share an insight, caveat, or question.
Aslam et al. (2019) conducted a case report in Pulmonary lymphangitic carcinomatosis secondary to Stage IV pancreatic cancer (n=1). Stage IV pancreatic cancer with pulmonary lymphangitic carcinomatosis was evaluated on Clinical outcome (mortality). A 52-year-old man with stage IV pancreatic cancer presented with rapidly deteriorating pulmonary lymphangitic carcinomatosis and succumbed to acute hypoxic respiratory failure within six weeks.
Synapse has enriched 10 related papers. Consider them for comparative context: